Common Stock, Value, Issued of Regen BioPharma Inc from 30 Sep 2013 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
- Summary
-
Regen BioPharma Inc quarterly Common Stock, Value, Issued in USD history and change rate from 30 Sep 2013 to 31 Dec 2025.
- Regen BioPharma Inc Common Stock, Value, Issued for the quarter ending 31 Dec 2025 was $10,806, a 401% increase year-over-year.
- Source SEC data
- View on sec.gov
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)
Regen BioPharma Inc Quarterly Common Stock, Value, Issued (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $10,806 | +$8,649 | +401% | 31 Dec 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
| Q3 2025 | $3,939 | +$3,412 | +647% | 30 Sep 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
| Q2 2025 | $3,157 | +$2,718 | +619% | 30 Jun 2025 | 10-Q | 11 Aug 2025 | 2025 | Q3 |
| Q1 2025 | $2,157 | +$1,745 | +424% | 31 Mar 2025 | 10-Q | 28 May 2025 | 2025 | Q2 |
| Q4 2024 | $2,157 | +$1,781 | +474% | 31 Dec 2024 | 10-Q | 16 May 2025 | 2025 | Q1 |
| Q3 2024 | $527 | +$175 | +50% | 30 Sep 2024 | 10-K | 30 Dec 2025 | 2025 | FY |
| Q2 2024 | $439 | +$100 | +29% | 30 Jun 2024 | 10-Q | 13 Aug 2024 | 2024 | Q3 |
| Q1 2024 | $412 | +$73 | +22% | 31 Mar 2024 | 10-Q | 24 Apr 2024 | 2024 | Q2 |
| Q4 2023 | $376 | -$504,467 | -100% | 31 Dec 2023 | 10-Q | 19 Jan 2024 | 2024 | Q1 |
| Q3 2023 | $352 | -$502,798 | -100% | 30 Sep 2023 | 10-K | 13 May 2025 | 2024 | FY |
| Q2 2023 | $339 | -$491,660 | -100% | 30 Jun 2023 | 10-Q | 25 Jul 2023 | 2023 | Q3 |
| Q1 2023 | $339 | -$457,660 | -100% | 31 Mar 2023 | 10-Q | 18 Apr 2023 | 2023 | Q2 |
| Q4 2022 | $504,843 | +$48,444 | +11% | 31 Dec 2022 | 10-Q | 19 Jan 2023 | 2023 | Q1 |
| Q3 2022 | $503,150 | +$68,096 | +16% | 30 Sep 2022 | 10-K | 20 Nov 2023 | 2023 | FY |
| Q2 2022 | $491,999 | +$113,981 | +30% | 30 Jun 2022 | 10-Q | 22 Jul 2022 | 2022 | Q3 |
| Q1 2022 | $457,999 | +$164,555 | +56% | 31 Mar 2022 | 10-Q | 21 Apr 2022 | 2022 | Q2 |
| Q4 2021 | $456,399 | +$230,399 | +102% | 31 Dec 2021 | 10-Q | 20 Jan 2022 | 2022 | Q1 |
| Q3 2021 | $435,054 | +$274,556 | +171% | 30 Sep 2021 | 10-K | 15 Nov 2022 | 2022 | FY |
| Q2 2021 | $378,018 | +$217,520 | +136% | 30 Jun 2021 | 10-Q/A | 22 Dec 2021 | 2021 | Q3 |
| Q1 2021 | $293,444 | +$132,946 | +83% | 31 Mar 2021 | 10-Q | 18 Aug 2021 | 2021 | Q2 |
| Q4 2020 | $226,000 | +$83,772 | +59% | 31 Dec 2020 | 10-Q | 13 Aug 2021 | 2021 | Q1 |
| Q3 2020 | $160,498 | +$100,500 | +168% | 30 Sep 2020 | 10-K | 22 Dec 2021 | 2021 | FY |
| Q2 2020 | $160,498 | +$108,655 | +210% | 30 Jun 2020 | 10-Q | 05 Aug 2021 | 2020 | Q3 |
| Q1 2020 | $160,498 | +$122,788 | +326% | 31 Mar 2020 | 10-Q | 05 Aug 2021 | 2020 | Q2 |
| Q4 2019 | $142,228 | +$117,025 | +464% | 31 Dec 2019 | 10-Q | 05 Aug 2021 | 2020 | Q1 |
| Q3 2019 | $59,998 | +$41,968 | +233% | 30 Sep 2019 | 10-Q | 05 Aug 2021 | 2020 | Q3 |
| Q2 2019 | $51,843 | +$35,972 | +227% | 30 Jun 2019 | 10-Q | 24 Oct 2019 | 2019 | Q3 |
| Q1 2019 | $37,710 | +$22,579 | +149% | 31 Mar 2019 | 10-Q | 29 Aug 2019 | 2019 | Q2 |
| Q4 2018 | $25,203 | +$10,586 | +72% | 31 Dec 2018 | 10-Q | 12 Feb 2019 | 2019 | Q1 |
| Q3 2018 | $18,030 | +$4,061 | +29% | 30 Sep 2018 | 10-K | 21 Jun 2021 | 2019 | FY |
| Q2 2018 | $15,871 | +$2,061 | +15% | 30 Jun 2018 | 10-Q | 06 Aug 2018 | 2018 | Q3 |
| Q1 2018 | $15,131 | +$1,321 | +9.6% | 31 Mar 2018 | 10-Q | 14 May 2018 | 2018 | Q2 |
| Q4 2017 | $14,617 | +$77 | +0.53% | 31 Dec 2017 | 10-Q | 06 Feb 2018 | 2018 | Q1 |
| Q3 2017 | $13,969 | -$1 | -0.01% | 30 Sep 2017 | 10-K | 27 Dec 2018 | 2018 | FY |
| Q2 2017 | $13,810 | +$357 | +2.7% | 30 Jun 2017 | 10-Q | 07 Aug 2017 | 2017 | Q3 |
| Q1 2017 | $13,810 | +$986 | +7.7% | 31 Mar 2017 | 10-Q | 05 May 2017 | 2017 | Q2 |
| Q4 2016 | $14,540 | +$2,113 | +17% | 31 Dec 2016 | 10-Q | 27 Jan 2017 | 2017 | Q1 |
| Q3 2016 | $13,970 | +$2,496 | +22% | 30 Sep 2016 | 10-Q | 27 Jan 2017 | 2017 | Q1 |
| Q2 2016 | $13,453 | +$2,100 | +18% | 30 Jun 2016 | 10-Q | 01 Aug 2016 | 2016 | Q3 |
| Q1 2016 | $12,824 | +$1,892 | +17% | 31 Mar 2016 | 10-Q | 29 Apr 2016 | 2016 | Q2 |
| Q4 2015 | $12,427 | +$7,222 | +139% | 31 Dec 2015 | 10-Q | 28 Jan 2016 | 2016 | Q1 |
| Q3 2015 | $11,474 | +$6,283 | +121% | 30 Sep 2015 | 10-K | 21 Dec 2016 | 2016 | FY |
| Q2 2015 | $11,353 | +$6,162 | +119% | 30 Jun 2015 | 10-Q | 29 Jul 2015 | 2015 | Q3 |
| Q1 2015 | $10,932 | +$5,741 | +111% | 31 Mar 2015 | 10-Q | 07 May 2015 | 2015 | Q2 |
| Q4 2014 | $5,205 | 31 Dec 2014 | 10-Q | 04 Feb 2015 | 2015 | Q1 | ||
| Q3 2014 | $5,191 | +$30 | +0.58% | 30 Sep 2014 | 10-K/A | 28 Apr 2017 | 2015 | FY |
| Q2 2014 | $5,191 | 30 Jun 2014 | 10-Q | 07 Aug 2014 | 2014 | Q3 | ||
| Q1 2014 | $5,191 | 31 Mar 2014 | 10-Q | 05 May 2014 | 2014 | Q2 | ||
| Q3 2013 | $5,161 | 30 Sep 2013 | 10-K | 18 Dec 2014 | 2014 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.